Protein misfolding plays a role in the pathogenesis of many diseases. ␣ 1 -Antitrypsin misfolding leads to the accumulation of long chain polymers within the hepatocyte, reducing its plasma concentration and predisposing the patient to emphysema and liver disease. In order to understand the misfolding process, it is necessary to examine the folding of ␣ 1 -antitrypsin through the different structures involved in this process. In this study we have used a novel technique in which unique cysteine residues were introduced at various positions into ␣ 1 -antitrypsin and fluorescently labeled with N,N-dimethyl-N-(iodoacetyl)-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-ethylenediamine. The fluorescence properties of each protein were studied in the native state and as a function of guanidine hydrochloride-mediated unfolding. The studies found that ␣ 1 -antitrypsin unfolded through a series of intermediate structures. From the position of the fluorescence probes, the fluorescence quenching data, and the molecular modeling, we show that unfolding of ␣ 1 -antitrypsin occurs via disruption of the A and C ␤-sheets followed by the B ␤-sheet. The implications of these data on both ␣ 1 -antitrypsin function and polymerization are discussed.
Protein folding is the process by which the primary sequence is translated into tertiary structure. Modification of this sequence via in vivo mutation or in vitro mutagenesis often alters the ability of the protein to fold correctly. Misfolding of proteins during their synthesis within the cell can lead to loss of protein function (1) , an example being ␣ 1 -antitrypsin (␣ 1 -AT) 1 deficiency (2) (3) (4) . Many well characterized ␣ 1 -AT variants are associated with an ␣ 1 -AT plasma deficiency; in these cases, the variants aggregate at their site of synthesis within the liver cell (5, 6 ). This aggregation is via an ordered polymerization process that is initiated by protein misfolding. In the case of the ␣ 1 -AT Z mutation (Glu-342 3 Lys), the rate of protein folding is much slower than in the native state, leading to the accumulation of an intermediate, which then polymerizes (4) . It has recently been shown that the heat-induced polymerization of ␣ 1 -AT also involves the formation of an unfolding intermediate (7) . The actual process of polymerization has been well studied, and two mechanisms have been proposed: the loop-A-sheet and loop-C-sheet mechanisms (8 -11) . Both processes involve the insertion of the reactive center loop residues of the donating ␣ 1 -AT molecule into either the A ␤-sheet (loop-A-sheet) or the C ␤-sheet (loop-C-sheet) of the acceptor molecule (11) . There is evidence for the occurrence of both of these mechanisms; indeed, in vitro ␣ 1 -AT has been shown to undergo both depending upon the buffer used (12) (13) (14) .
␣ 1 -AT is a member of the serine proteinase inhibitor (serpin) superfamily and is composed of 394 amino acid residues arranged into three ␤-sheets (A, B, and C) and nine ␣-helices (A-I). X-ray crystallographic and biochemical data have shown that ␣ 1 -AT can adopt a number of different structures (15) (16) (17) . These data demonstrate that areas such as the reactive center loop and the A ␤-sheet of ␣ 1 -AT are extremely mobile, which is an essential requirement for inhibitory activity. Mutations that affect the mobility of ␣ 1 -AT cause it to become either a proteinase substrate or to undergo polymerization (16, 18 -20) . Although many studies have examined the structural changes of a serpin in relation to inhibitory mechanism, the conformational changes, which occur during folding and misfolding, have not yet been characterized.
The unfolding pathway of ␣ 1 -AT has been investigated using size exclusion chromatography, intrinsic fluorescence, circular dichroism, and urea gradient gel electrophoresis (21) (22) (23) . These studies revealed the presence of multiple intermediates, the conformations of which have never been examined. A number of methods have been employed for other proteins to study the conformational changes during folding. The formation of disulfide bonds has been widely used to trap folding intermediates (24) , but ␣ 1 -AT contains only a single cysteine residue. NMR methodology has been used to examine the rate of exchange between backbone amide protons of the folding protein and the solvent (25); however, due to the large size of ␣ 1 -AT, this method is not applicable. Another commonly adopted technique involves the insertion of unique tryptophan residues (26, 27) . The changes in tryptophan residue fluorescence upon folding are then followed spectrophotometrically, yielding information about the events occurring at specific locations within the protein structure. ␣ 1 -AT possesses two tryptophan residues, one of which (Trp-194) is highly conserved and essential for activity (3) . Therefore, the insertion of additional tryptophan residues would lead to a mixed population.
In order to study the folding of ␣ 1 -AT, we propose a novel approach in which we have fluorescently labeled unique cysteine residues that have been inserted at positions throughout the tertiary structure of the molecule. The fluorescence properties of these unique groups were then examined as a function of denaturant concentration. The results demonstrate that the equilibrium unfolding pathway of ␣ 1 -AT consists of at least one stable intermediate structure, which we have begun to characterize.
EXPERIMENTAL PROCEDURES
Materials-1,1Ј-Bis-4-anilino-5-napthalinsulfonic acid (dipotassium salt) and N,NЈ-dimethyl-N-(iodoacetyl)-NЈ-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine (IANBD) were purchased from Molecular Probes Inc. (Eugene, OR). Ultrapure grade guanidine hydrochloride (Gdn HCl) was obtained from ICN Biochemicals.
Production of Proteins-The recombinant ␣ 1 -AT proteins were expressed in E. coli strain BL21 (DE3) as described previously (28) . The proteins were purified from cell inclusion bodies using Gdn HCl denaturation and a continual dilution procedure as recently described (29) . In this study recombinant ␣ 1 -AT (P1ϭArg) was used as the control and the construction of ␣ 1 -AT (S313C) and ␣ 1 -AT (P3ЈCys) have been described (12) . The protein concentration was determined by Bradford assay against a standard of purified recombinant ␣ 1 -AT, the concentration of which had been determined by amino acid analysis. The association rate constant (k ass ) and stoichiometry of inhibition were measured using thrombin for both the unlabeled and labeled ␣ 1 -AT forms, as described previously (30) . Fluorescent labeling of the proteins with IANBD was performed as described previously (12) . The extent of labeling was determined using the extinction coefficient of IANBD (⑀ ϭ 25,000 M Ϫ1 cm Ϫ1 ). Spectroscopic Methods-Fluorescence emission spectra were recorded on a Perkin-Elmer LS50B spectrofluorometer, using a thermostatted cuvette holder at 25°C in a 1-cm path length quartz cell. Excitation and emission slits were set at 2.5 nm for all spectra, and a scan speed of 10 nm/min was used. The absorbance at the excitation wavelengths was monitored in all experiments and remained below 0.05. Circular dichroism spectra were measured on a Jasco 720s spectropolarimeter at 25°C. Far UV spectra from 190 to 250 nm were collected with 5 s/point signal averaging; 222 measurements were made with the signal averaged over 60 s. The concentration of ␣ 1 -AT used was 0.1 mg/ml with a 0.1-cm path length cell.
Denaturation Transitions-Unfolding curves were determined by either measuring the fluorescence emission spectra of a 200 nM protein solution as a function of denaturant concentration or the change in signal at 222 nm in the far UV as a function of denaturant concentration. Attempts at measuring the near UV CD unfolding curve proved impractical due to protein precipitation at the concentrations required. Previous studies (31) and our own preliminary data have shown that unfolding in Gdn HCl reaches equilibrium within a matter of minutes at all concentrations of Gdn HCl used. Therefore, the samples were allowed to equilibrate at 25°C for 2 h before measurement. For both the labeled and unlabeled proteins, the reversibility of the unfolding process was established by adding buffer to samples of unfolded protein, allowing each to re-equilibrate at a lower Gdn HCl concentration. The fluorescence emission spectra acquired for these samples, when corrected for dilution, were identical with corresponding samples that had reached equilibrium from the folded state, thus confirming the reversibility of the systems. The inhibitory activity of these refolded proteins was also analyzed, and they were found to be fully active.
Unfolding Data Analysis-The Gdn HCl denaturation curves were fitted to either a two-state or three-state unfolding model, using a nonlinear least-squares fitting algorithm. Raw equilibrium data were fitted directly to a two-state model of denaturation in which the baselines are fitted simultaneously with the unfolding transition (32) . A three-state model was also employed for analysis of the denaturation curves based upon the mechanism F 7 I 7 U, where F and U are the fully folded and unfolded forms of the protein, respectively, and I is an intermediate that is populated at equilibrium (33) .
Fluorescence Quenching Experiments-Fluorescence quenching measurements were performed in 50 mM Tris, pH 8.0, at 0 and 1 M Gdn HCl. Aliquots of KI (2 M stock) containing 1 mM Na 2 S 2 O 3 were added to protein solutions (200 nM), and the change in fluorescence emission intensity of the tryptophan residues ( ex ϭ 290 nm) and covalently bound IANBD ( ex ϭ 480 nm) were measured. Measurements in the presence of 1 M Gdn HCl were made on individual samples, so there was no dilution of the Gdn HCl. The data were analyzed as described previously by Lehrer (34) . All data were corrected for inner filter effects where necessary.
RESULTS

Fluorescence Properties of ␣ 1 -AT and Its
Variants-The aim of this study was to monitor the structural changes of ␣ 1 -AT as it unfolds. To achieve this, we generated ␣ 1 -AT variants, which were fluorescently labeled at specific sites on the protein. The structural changes occurring in the unfolding process were then characterized using the site-specific fluorescence changes. ␣ 1 -AT possesses a unique cysteine residue (Cys-232), which is situated on strand s2B (Fig. 1) . Two further cysteine residues were introduced into ␣ 1 -AT at positions P3Ј 2 and Ser-313 ( Fig.  1 ). The substitutions were made using an ␣ 1 -AT variant, in which Cys-232 had been replaced by a serine residue. This variant has previously been shown to have the same activity as the native protein (12, 28) . The native and mutant constructs were efficiently expressed as inclusion bodies and purified as described previously (16) . The two mutations (P3ЈCys and S313C) had no effect upon the inhibitory properties of the proteins (Table I ). These cysteine residues were then selectively labeled with the fluorescent probe IANBD. The extent of modification was measured using the extinction coefficient of the probe and was found to be 1:1 in all cases; this also confirmed the insertion of one unique cysteine residue per monomer. The presence of the fluorescent label had no effect upon the inhibitory properties of the protein (Table I ).
The addition of the IANBD label affords the protein new fluorescence properties. The fluorescence emission spectra of the three labeled proteins show distinct differences depending upon the location of the probe within the ␣ 1 -AT structure (Fig. 2) . The fluorescently labeled wild type protein (␣ 1 -AT Cys-232-IANBD) ) had an emission maximum at 531 nm, whereas the two other proteins exhibited emission maxima at 527 nm (␣ 1 -AT (S313C-IANBD) ) and 532 nm (␣ 1 -AT (P3ЈCys-IANBD) ) (Fig. 2 ). These spectra indicate that the environment of the fluorescence probes at Cys-232 and P3ЈCys are more solvent-exposed than the probe at Cys-313. Although the labeled proteins were fully active (Table I) , there was the possibility that the presence of the IANBD altered the structure of the native state. To examine this, we carefully measured the tryptophan emission spectra and far UV CD spectra for all labeled and unlabeled proteins. Both the tryptophan emission spectra and far UV CD spectra for the three labeled proteins were identical to the unlabeled fluorescence and CD spectra (data not shown). These data, in conjunction with the full inhibitory activity of the proteins, demonstrate that the mutations and the covalent modification had no significant effect upon the native structure of the proteins.
Unfolding Studies-The fluorescence characteristic of these novel ␣ 1 -AT variants allows the solvent induced denaturation of ␣ 1 -AT to be followed spectrofluorometrically. The fluorescence properties of both the tryptophan residues and the covalently attached probe were monitored following treatment 2 The nomenclature for residues within the reactive center loop is based on that described by Schechter and Berger (46) for the substrates of proteases. with various concentrations of Gdn HCl. Incubation of the proteins in 6 M Gdn HCl resulted in the emission maximum of the tryptophan residues (for all three proteins) becoming red shifted from 337 to 352 nm, concomitant with an increase in fluorescence emission intensity (Fig. 3A) . This demonstrates that the tryptophan residue fluorescence is heavily quenched in the native structure. The emission spectra of the probes under the same conditions showed a red shift to 538 nm and a decrease in fluorescence intensity (Fig. 3B) . Fig. 4 shows the normalized changes in max as a function of denaturant concentration for both the tryptophan residues and the probes. There was little change in the max from the tryptophan residues below 1 M Gdn HCl for all the variants. Between 1 and 3.5 M Gdn HCl, max increased (Fig. 4A) , indicating an increase in solvent exposure of the tryptophan residues as the protein unfolds. The spectral changes associated with denaturation of the modified proteins were unique to the probe position (Fig. 4B) . The labeled variants and unlabeled ␣ 1 -AT exhibited the same tryptophan fluorescence change as a function of Gdn HCl concentration, with a midpoint of 2.5 M Gdn HCl (Fig. 4A , Table  II ). Analysis of these data using a two-state folding model allows calculation of ⌬G F3 U , (the free energy of unfolding in water) and m (a constant that is proportional to the increase in degree of exposure of the protein on denaturation) (Table II) . It can be seen that ⌬G F3 U is the same for both the unlabeled and labeled proteins, with an average value of 2.22 Ϯ 0.03 kcal/mol. In addition, there is no significant difference in m with an average value of 0.885 Ϯ 0.02 kcal/mol/M. The coincidence of these labeled and unlabeled data suggests that the fluorescent probes do not perturb the equilibrium-unfolding pathway. The probe fluorescence changes are nonsuperimposable (Fig.  4B) , implying that the probes are reporting site specific conformational changes. The data in Fig. 4B were analyzed by either a two-state or three-state mechanism as described previously (25, 35) . It was found that the data for ␣ 1 -AT (S313C-IANBD) and ␣ 1 -AT (Cys-232-IANBD) could be adequately described by the twostate analysis, whereas ␣ 1 -AT (P3ЈCys-IANBD) could only be described using a three-state analysis. The data in Table II and Fig. 4B show that ␣ 1 -AT (Cys-232-IANBD) has the highest denaturation midpoint (2.8 M Gdn HCl), compared with the tryptophan observed transition (2.5 M Gdn HCl). This indicates that the regions around the tryptophan residues and Cys-232 are significantly more resistant to denaturation than the regions around P3ЈCys and Cys-313. The denaturation midpoint for -232-IANBD) . B, probe emission spectra ex ϭ 480 nm of the native (---) and denatured (-----) ␣ 1 -AT (Cys-232-IANBD) . The bandpass was 2.5 nm, and the temperature was 25°C for both sets of spectra.
␣ 1 -AT (Cys-313-IANBD) is 1.7 M, over 1 M lower than the value obtained for ␣ 1 -AT (Cys-232-IANBD). The midpoint for the first transition of ␣ 1 -AT (P3ЈCys-IANBD) is 0.4 M Gdn HCl, whereas the midpoint of the second transition is 2.5 M Gdn HCl. This is similar to the values obtained from the tryptophan residue and ␣ 1 -AT (Cys-232-IANBD) analysis, suggesting that they may be monitoring the same transition. These data also imply that the regions around both P3ЈCys and Cys-313 are relatively unstable. In contrast, the region around Cys-232 and the tryptophan residues unfold at higher Gdn HCl concentrations, demonstrating an increased stability compared with the other regions. The sequential spectral changes demonstrate that ␣ 1 -AT unfolding is not a simple two-state process, in which only the fully folded and unfolded states exist. In this case, there appears to be at least one intermediate state, and the protein only becomes fully unfolded at concentrations above 5 M Gdn HCl.
It is possible that the differences in probe monitored unfolding profiles are due to local destabilizing effects of the probe. To assess this, the unfolding curves for the labeled protein were measured using far UV CD (Fig. 5) . Far UV CD measures secondary structure; therefore, deviation in the unfolding profile from native will indicate that the probes are affecting the unfolding process. However, it can be seen in Fig. 5 that the unfolding profiles for all the labeled proteins are essentially the same as the unlabeled native structure. The far UV CD data show two transitions, with average midpoints of 0.77 and 2.6 M Gdn HCl (Table II) . This is similar to the fluorescence changes observed for ␣ 1 -AT (P3ЈCys-IANBD) ; however, the midpoints of the transitions were approximately 0.2 M higher when measured by far UV CD. We cannot discount the possibility that minor local perturbations of the ␣ 1 -AT structure due to labeling may have occurred. However, the coincidence of 1) tryptophan unfolding data (Fig. 4A) , 2) far UV CD unfolding data (Fig. 5), 3) tryptophan emission spectra (data not shown), and 4) far UV CD spectra (data not shown) of the labeled proteins compared with native ␣ 1 -AT strongly suggests that the probes do not interfere with the equilibrium unfolding process. (Fig. 5) , and the fluorescence data suggest that the environment around P3ЈCys, S313C, and the two tryptophan residues has been altered (Fig. 4) . The structure of this equilibrium intermediate state was further characterized by fluorescence quenching experiments. This technique measures the accessibility of a nonfluorescent quenching agent, such as iodide, to the fluorescence group, providing another means of characterizing the nature of the intermediate. Various amounts of iodide were added to the native (0 M Gdn HCl) and intermediate (formed in 1 M Gdn HCl) states of ␣ 1 -AT, and then the changes in the tryptophan and probe emission intensity were monitored. The Stern-Volmer plot for both the tryptophan residues and IANBD labeled proteins were linear over the concentration range studied (Fig. 6. ) At 1 M Gdn HCl, the tryptophan residues became far more accessible to iodide than in the native state, with an almost 2-fold increase in K sv (Table I) . Similar increases in K sv were also seen for ␣ 1 -AT (Cys-232-IANBD) and ␣ 1 -AT (P3ЈCys-IANBD) in 1 M Gdn HCl. Interestingly, although the spectral properties of ␣ 1 -AT (S313C-IANBD) in 1 M Gdn HCl changed, there was no change in K sv (Table I) .
DISCUSSION
Unfolding Pathway of ␣ 1 -Antitrypsin-Investigations into the pathways by which globular proteins fold are essential to understanding their structural organization. This information is also critical if we are to understand the molecular basis for protein misfolding diseases. In this study, we have characterized the unfolding pathway of ␣ 1 -AT using a combination of spectroscopic techniques. We have placed the fluorescent probe, IANBD, in unique positions within ␣ 1 -AT to obtain information about the movement of specific structural motifs as the protein unfolds. This was achieved by inserting cysteine residues at selected sites and then covalently modifying them with the cysteine reactive probe IANBD. The positions of the fluorescent probes used in this study are shown in Fig. 1 . P3ЈCys is situated on the first strand of the C ␤-sheet (s1C) (Fig. 1) . Chang et al. (11) immobilized s1C using an engineered disulfide bond and found that polymerization did not occur, indicating that mobility of s1C is essential for this process. Cys-232 is the native cysteine residue and is exposed at the rear of the molecule on the B ␤-sheet (s2B) (Fig. 1) . Cys-313 is located at the base of the serpin molecule on a loop connecting strands 5A and 6A of the A ␤-sheet (Fig. 1) . A detailed structural comparison between native and cleaved ␣ 1 -AT showed that this region moves upon reactive center loop insertion into the A ␤-sheet (36); therefore, this probe will monitor changes in The raw fluorescence emission data were converted to plots of F app versus denaturant concentration as described previously (33) . A, unfolding was monitored by changes in the Trp residue fluorescence emission maximum ( ex ϭ 290 nm). B, unfolding was monitored by changes in the probe fluorescence emission maximum ( ex ϭ 480 nm). The lines show the two-state and three-state curves fitted as described under "Experimental Procedures." A two-state model was used for all fits except for the probe fluorescence change of ␣ 1 -AT (P3ЈCys-IANBD) , where a three-state model was employed.
the A ␤-sheet and in the surrounding regions. The fluorescent properties of the native tryptophan residues (194 and 238) were also used in this study. Trp-194 is at the top of s3A and is sandwiched between the A and B ␤-sheets, whereas Trp-238 on s3B is partially exposed to the solvent. Previous studies have shown that Trp-194 is the major contributor to the fluorescence properties of ␣ 1 -AT (3, 37) .
Two-state unfolding has been observed in only a few small monomeric proteins (38) . It is often characterized by the coincidence of unfolding curves monitored using different spectral probes. Fig. 4B shows that the fluorescence changes are nonsuperimposable when the different fluorescent probes are used to follow the unfolding pathway. This implies that the probes placed in different positions within ␣ 1 -AT are reporting local structural changes. Therefore, ␣ 1 -AT unfolds via a series of structures. It can be argued that the presence of the fluorescence probes themselves affects the ␣ 1 -AT unfolding pathway. We cannot entirely discount this; however, we have shown that the tryptophan residue and far UV CD spectral changes for the labeled proteins are indistinguishable from the native protein during unfolding. Furthermore, the labeled proteins are fully active as inhibitors. Although small perturbations due to the presence of the probes cannot be ruled out, we believe that the probes are reporting genuine structural changes.
Examination of the x-ray crystal structure of native ␣ 1 -AT (17) in conjunction with the fluorescence and far UV CD data allows insight into the structural changes as ␣ 1 -AT unfolds. It is evident that the probes placed at P3ЈCys and Cys-313 are in regions of structure that are significantly less resistant to denaturation than the structural areas around Cys-232 and the tryptophan residues (Fig. 4, A and B) . The midpoint of unfolding for both ␣ 1 -AT (P3Ј3C-IANBD) (first transition) and ␣ 1 -AT (S313C-IANBD) occurs at significantly lower Gdn HCl concentrations than the corresponding values for ␣ 1 -AT (P1ϭArg) and ␣ 1 -AT (C232S-IANBD) . It has previously been shown that conformational changes in the reactive center loop and s1C cause a movement at the base of the serpin (36) . Therefore, the initial unfolding event, which occurs at low Gdn HCl concentrations, may represent a movement in the reactive center loop and an opening of the A ␤-sheet. This would alter the spectral properties of the fluorescence probes at positions P3ЈCys and Cys-313. Conformational changes in these areas would be predicted not to affect the region around Cys-232, and indeed the emission maximum of Cys-232 was unaffected. The circular dichroism of the structure at 1 M Gdn HCl in the far UV (222 nm) is decreased approximately 20% (Fig. 5) , suggesting partial unfolding and disruption of some secondary structure. This decrease may represent a local loss of secondary structure as indicated by the changes in the fluorescence of the probes at I3 U represent the midpoint of denaturation for the F3 U, F3 I, and I3 U transitions respectively. Presented are the two-and three-state analyses of the fluorescence probe data (Fig. 4B ) and the two-state analysis of the tryptophan fluorescence data (Fig 4A) and the three-state analysis of the far-UV CD data (Fig. 5) P3Cys-IANBD) . ␣ 1 -AT (P3ЈCys-IANBD) (200 nM) was titrated with KI, and the fluorescence emission intensity ( ex ϭ 290 nm; em ϭ 337 nm) was recorded after each addition. In the presence of 1 M Gdn HCl, KI was added to individual samples so that the Gdn HCl was not diluted. f represents the states of native ␣ 1 -AT (P3ЈCys-IANBD) , and छ represents ␣ 1 -AT (P3ЈCys-IANBD) in the presence of 1 M Gdn HCl. The lines represent a least-squares fit of the experimental data as described previously (34) positions P3ЈCys and Cys-313. There is a small change (Ͻ 8%) in the environment of the tryptophan residues at 1 M Gdn HCl. Kwon et al. (37) predicted that the opening of the A ␤-sheet would make Trp-194 more accessible to solvent and hence alter its fluorescence properties. This was confirmed by the 2-fold increase in the Stern-Volmer constant of the tryptophan residues (Table I ). Complete disruption of the A ␤-sheet has been shown to account for the change in tryptophan fluorescence (37) ; therefore, the small change we observed at low denaturant concentrations may represent a prelude to this conformational change.
An increase in the denaturant concentration causes further structural changes in the protein that leads to complete unfolding. As a result, the probes at P3ЈCys and Cys-313 become fully exposed to solvent, and the major portion of the tryptophan residue fluorescence transition occurs. The final conformational change observed using these probes is the disruption of the area around the B ␤-sheet (Cys-232). These data demonstrate that the B ␤-sheet region is the most resistant to denaturant. The pathway of conformational change suggested by these fluorescence data begins with an opening at the top of the A ␤-sheet and a movement in s1C to form a stable intermediate. This is then followed by the unfolding of the A and C ␤-sheet regions, which in turn leads to loss of the B ␤-sheet and formation of the unfolded structure.
␣ 1 -AT and other serpins can undergo a conformational switch termed the stressed (native) to relaxed (latent) transition. This transition is crucial to the inhibitory properties of the serpin family (5, 39) . The area that holds the molecule in this trapped, stressed state has been located to a region within the hydrophobic core of the molecule (37, 39) . Through side chain locking, these core residues prevent the rearrangement of native ␣ 1 -AT into a more stable but inactive state (39) . Our study suggests that the residues that make up this core around the B ␤-sheet are unaffected by low denaturant concentrations. Therefore, this arrangement is intact in the intermediate structure formed in 1 M Gdn HCl. Once the denaturant concentration is increased, the residues within the core region become disordered and the molecule unfolds completely. These data suggest that regions within the serpin molecule have evolved that are significantly more resistant to denaturant than others; this has implications for both the inhibitory mechanism and polymerization process.
Implications for Serpin Mechanism-Specific parts of the structure of a serpin, such as the reactive center loop and hinge region, are extremely flexible; this mobility is required for their inhibitory function (16, 20, 28) . In recent years, the conformational changes that occur within the serpin structure when bound to a proteinase have been intensively studied (40, 41) . Recent studies suggest that the proteinase, once docked to the exposed reactive center loop, attempts to cleave the scissile bond, which causes the reactive center loop to insert into the A ␤-sheet. The extent of this insertion is unknown; however, biophysical studies have shown that the effect is to move the proteinase from the top of the molecule to a position probably on the face of the A ␤-sheet (40, 41) . The unfolding results presented above explain how ␣ 1 -AT is designed to undergo these conformational changes. We show here that the regions around the top and bottom of the A ␤-sheet are less stable than the other parts of the molecule, unfolding at lower Gdn HCl concentrations. Comparison of x-ray crystallographic structures of native and cleaved serpins show that the area around Ser-313 moves upon either full (complete A ␤-sheet opening) or partial (partial A ␤-sheet opening) reactive center loop insertion (36) . Furthermore, the x-ray crystal structures of latent antithrombin (10) and plasminogen activator inhibitor-1 (42) demonstrate the mobility of s1C. The B ␤-sheet represents a stable platform for these conformational changes, and our study shows that this is a far more stable region in the protein (unfolding with a midpoint at 2.8 M Gdn HCl). The data presented herein show that the region around the top of the A ␤-sheet of ␣ 1 -AT is more flexible and facilitates movement of the reactive center loop into the A ␤-sheet once the proteinase is bound.
Implications for Serpin Polymerization-The fluorescence data in this paper showed that the top of the A ␤-sheet is more flexible than the rest of the molecule, and this is required for correct serpin function. However, if this instability is enhanced due to mutations, this can induce the unwanted effect of polymerization. ␣ 1 -AT polymerization in vivo leads to a plasma deficiency of the inhibitor and eventually to lung and liver damage (6, 43) . A number of mutations have been identified that cause the A ␤-sheet movement to be disturbed (9, 44, 45 ). An alternative explanation may be that these mutations alter further the conformational instability of this region, which would lead to an open A ␤-sheet, and therefore increased chances of polymerization and disease.
